Page last updated: 2024-08-20

2-chloroadenosine and Symptom Cluster

2-chloroadenosine has been researched along with Symptom Cluster in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
DeJoy, SQ; Jeyaseelan, R; Kerwar, SS; Schow, SR; Torley, LW; Wick, MM	1

Other Studies

1 other study(ies) available for 2-chloroadenosine and Symptom Cluster

Article	Year
Attenuation of interleukin 2-induced pulmonary vascular leak syndrome by low doses of oral methotrexate. Cancer research, 1995, Nov-01, Volume: 55, Issue:21 Topics: 2-Chloroadenosine; Administration, Oral; Animals; Antibodies; Antimetabolites, Antineoplastic; Capillary Permeability; Dose-Response Relationship, Drug; G(M1) Ganglioside; Interleukin-2; Killer Cells, Lymphokine-Activated; Lung; Male; Methotrexate; Mice; Mice, Inbred C57BL; Pulmonary Circulation; Receptors, Tumor Necrosis Factor; Syndrome; Tumor Necrosis Factor-alpha	1995

Article

Year

Attenuation of interleukin 2-induced pulmonary vascular leak syndrome by low doses of oral methotrexate.

Cancer research, 1995, Nov-01, Volume: 55, Issue:21

Topics: 2-Chloroadenosine; Administration, Oral; Animals; Antibodies; Antimetabolites, Antineoplastic; Capillary Permeability; Dose-Response Relationship, Drug; G(M1) Ganglioside; Interleukin-2; Killer Cells, Lymphokine-Activated; Lung; Male; Methotrexate; Mice; Mice, Inbred C57BL; Pulmonary Circulation; Receptors, Tumor Necrosis Factor; Syndrome; Tumor Necrosis Factor-alpha

1995